A community-based feasibility study using wheat bran fiber supplementation to lower colon cancer risk.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 1647531.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this feasibility study, free-living older adults (n = 180; means = 67.5 years old) were randomly assigned to one of three levels of a 3-month standardized compliance enhancement program. Regarding subject compliance with the 18 g/day wheat bran fiber supplement, the high compliance enhancement group had a superior regimen compliance rate (88%) versus the medium and low groups, (66 and 29%, respectively) (P = 0.01), with similar attrition rates. No significant gastrointestinal side effects and changes in body weight were reported. For similar efficacy, the comprehensive compliance enhancement group had the greatest cost effectiveness.
Medical subject headings
- Colonic Neoplasms
- Community Health Services
- Dietary Fiber
- Patient Education as Topic
- Triticum